Free Trial

Abbott Laboratories (ABT) Competitors

Abbott Laboratories logo
$133.41 +0.05 (+0.04%)
Closing price 07/9/2025 03:56 PM Eastern
Extended Trading
$133.04 -0.38 (-0.28%)
As of 07/9/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ABT vs. DXCM, ISRG, TSLA, ABBV, BSX, ELV, ITGR, JNJ, MDT, and TMO

Should you be buying Abbott Laboratories stock or one of its competitors? The main competitors of Abbott Laboratories include DexCom (DXCM), Intuitive Surgical (ISRG), Tesla (TSLA), AbbVie (ABBV), Boston Scientific (BSX), Elevance Health (ELV), Integer (ITGR), Johnson & Johnson (JNJ), Medtronic (MDT), and Thermo Fisher Scientific (TMO).

Abbott Laboratories vs. Its Competitors

DexCom (NASDAQ:DXCM) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

In the previous week, Abbott Laboratories had 62 more articles in the media than DexCom. MarketBeat recorded 83 mentions for Abbott Laboratories and 21 mentions for DexCom. DexCom's average media sentiment score of 1.35 beat Abbott Laboratories' score of 1.05 indicating that DexCom is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DexCom
17 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Abbott Laboratories
53 Very Positive mention(s)
7 Positive mention(s)
14 Neutral mention(s)
5 Negative mention(s)
3 Very Negative mention(s)
Positive

DexCom has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500.

Abbott Laboratories has higher revenue and earnings than DexCom. Abbott Laboratories is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DexCom$4.03B8.25$576.20M$1.3463.34
Abbott Laboratories$41.95B5.53$13.40B$7.7117.30

97.8% of DexCom shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.3% of DexCom shares are held by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Abbott Laboratories has a net margin of 31.89% compared to DexCom's net margin of 12.90%. DexCom's return on equity of 30.05% beat Abbott Laboratories' return on equity.

Company Net Margins Return on Equity Return on Assets
DexCom12.90% 30.05% 10.00%
Abbott Laboratories 31.89%19.01%10.82%

DexCom presently has a consensus target price of $98.50, indicating a potential upside of 16.06%. Abbott Laboratories has a consensus target price of $143.11, indicating a potential upside of 7.27%. Given DexCom's stronger consensus rating and higher possible upside, analysts plainly believe DexCom is more favorable than Abbott Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DexCom
0 Sell rating(s)
4 Hold rating(s)
15 Buy rating(s)
3 Strong Buy rating(s)
2.95
Abbott Laboratories
0 Sell rating(s)
6 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.76

Summary

DexCom beats Abbott Laboratories on 10 of the 17 factors compared between the two stocks.

Get Abbott Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ABT vs. The Competition

MetricAbbott LaboratoriesMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$232.02B$10.41B$5.51B$20.51B
Dividend Yield1.77%2.09%5.25%3.74%
P/E Ratio17.3016.4028.0527.90
Price / Sales5.5331.20440.2940.80
Price / Cash20.2622.7937.0622.25
Price / Book4.833.728.124.59
Net Income$13.40B$235.43M$3.16B$982.91M
7 Day Performance-0.21%2.31%3.15%0.11%
1 Month Performance-0.47%2.59%3.49%3.55%
1 Year Performance29.51%-10.94%34.06%13.79%

Abbott Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABT
Abbott Laboratories
4.9117 of 5 stars
$133.41
+0.0%
$143.11
+7.3%
+31.3%$232.02B$41.95B17.30114,000Trending News
Upcoming Earnings
Analyst Forecast
DXCM
DexCom
4.8695 of 5 stars
$82.94
+0.0%
$98.50
+18.8%
-23.4%$32.53B$4.03B61.9210,300Positive News
ISRG
Intuitive Surgical
4.6811 of 5 stars
$533.93
-1.9%
$588.95
+10.3%
+19.4%$191.36B$8.35B78.2815,638Positive News
Analyst Forecast
TSLA
Tesla
4.5017 of 5 stars
$294.10
-6.7%
$301.60
+2.5%
+12.8%$946.70B$95.72B161.49125,665Trending News
Analyst Downgrade
Insider Trade
Analyst Revision
ABBV
AbbVie
4.9471 of 5 stars
$187.35
-1.0%
$211.29
+12.8%
+13.5%$330.93B$56.33B79.7255,000Trending News
Analyst Revision
BSX
Boston Scientific
4.6414 of 5 stars
$103.48
-0.8%
$116.09
+12.2%
+34.6%$153.09B$16.75B75.5353,000Trending News
ELV
Elevance Health
4.967 of 5 stars
$346.59
-0.4%
$498.87
+43.9%
-34.6%$78.30B$177.01B13.52104,200Analyst Forecast
ITGR
Integer
3.6575 of 5 stars
$116.55
-3.7%
$145.00
+24.4%
+4.7%$4.07B$1.72B55.2311,000
JNJ
Johnson & Johnson
4.8709 of 5 stars
$155.04
-0.6%
$170.88
+10.2%
+6.1%$373.04B$88.82B17.25138,100Trending News
Upcoming Earnings
MDT
Medtronic
4.6038 of 5 stars
$87.52
-1.0%
$97.87
+11.8%
+15.9%$112.25B$33.54B24.1895,000Trending News
Analyst Forecast
TMO
Thermo Fisher Scientific
4.9946 of 5 stars
$417.62
-2.7%
$604.05
+44.6%
-21.1%$157.65B$42.88B24.49125,000Positive News
Analyst Forecast

Related Companies and Tools


This page (NYSE:ABT) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners